Scientists are developing the first-ever pill to prevent Lyme disease, potentially protecting millions from tick-borne illnesses. Here's what you need to know.
A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the Montreal Neurological Institute-Hospital. Dr. Olivier Blanchard and his team want ...
A new Dartmouth study, published in Parasites and Vectors, finds that 50% of adult blacklegged ticks carry the bacteria that causes Lyme disease while up to 25% of the younger (nymph) blacklegged ...
Analysts expect the treatment to bring in more than $1 billion ... Shagun Singh said the deal fit strategically into J&J's neurological drugs division, an important area for the company.